Brief: Edesa Biotech Reports Positive Results In Phase 3 Respiratory Study

Edesa Biotech

28/10/2025 12:10

Edesa Biotech Inc EDSA.O:

EDESA BIOTECH REPORTS POSITIVE RESULTS IN PHASE 3 RESPIRATORY STUDY

EDESA BIOTECH INC: STUDY MET PRIMARY AND SECONDARY ENDPOINTS

EDESA BIOTECH INC - PARIDIPRUBART SHOWS 25% REDUCTION IN RISK OF DEATH

EDESA BIOTECH INC - EB05 WELL-TOLERATED IN SAFETY POPULATION OF OVER 275 SUBJECTS

EDESA BIOTECH INC - PARIDIPRUBART PLUS SOC SHOWS 13% IMPROVEMENT IN SURVIVAL

Source text: ID:nGNX1FjRDp

Further company coverage: EDSA.O